Attached files
file | filename |
---|---|
10-K - FORM 10-K ANNUAL REPORT - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_10k.htm |
EX-23.1 - EXHIBIT 23.1 AUDITOR'S CONSENT - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_ex23z1.htm |
EX-32.2 - EXHIBIT 32.2 SECTION 906 CERTIFICATION - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_ex32z2.htm |
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_ex31z1.htm |
EX-21.1 - EXHIBIT 21.1 SUBSIDIARIES - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_ex21z1.htm |
EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_ex31z2.htm |
EX-10.07 - EXHIBIT 10.07 INDEMNIFICATION AGREEMENT - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_ex10z07.htm |
EX-10.17 - EXHIBIT 10.17 LEASE EXTENSION - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_ex10z17.htm |
EX-10.06 - EXHIBIT 10.06 INDEMNIFICATION AGREEMENT - LIBERATOR MEDICAL HOLDINGS, INC. | f10k093015_ex10z06.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Mark A. Libratore, the President and Chief Executive Officer of Liberator Medical Holdings, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
This Annual Report on Form 10-K of the Company for the fiscal year ended September 30, 2015 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
2.
The information contained in this Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: December 14, 2015
/s/ Mark A. Libratore
Mark A. Libratore,
President and Chief Executive Officer